Skip to content

Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy

Continuous Preperitoneal Analgesia Versus Thoracic Epidural Analgesia After Open Pancreaticoduodenectomy: a Randomized Controlled Open-labeled Noninferiority Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04375826
Acronym
Pain
Enrollment
146
Registered
2020-05-05
Start date
2020-11-13
Completion date
2024-12-31
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management, Pain, Postoperative

Keywords

Pain management, Postoperative pain

Brief summary

This is a prospective randomized open-label noninferiority trial that compares thoracic epidural analgesia and continuous preperitoneal analgesia after open pancreaticoduodenectomy.

Detailed description

In the Enhanced recovery after surgery (ERAS) program of pancreaticoduodenectomy (PD), thoracic epidural analgesia (or epidural analgesia) was considered to be a key analgesic method because it not only effectively controls pain, but also lowers insulin resistance and helps restore bowel movement. However, epidural analgesia can cause a number of side effects despite of effective pain control. Epidural analgesia reduces peripheral vascular resistance by blocking sympathetic nerves with local anesthetics and may cause hypotension and decreasing heart rate. In addition, it can cause orthostatic hypotension, which can interfere with early ambulation after operation. In rare cases, there are potential complications of epidural abscess, meningitis, and epidural hematoma. Continuous peritoneal analgesia using local anesthetics has recently been used as an alternative analgesic to epidural analgesia in open abdomen surgery. This is easier to perform than epidural analgesia and is known to have fewer side effects. Recently, a non-inferiority comparison study have revealed that peritoneal analgesic was not inferior to epidural analgesia in terms of pain control. However, this study included a variety of operations other than PD, and most of the incisions were substernal, not midline. In addition, the method for mounting the epidural catheter was not described. The failure rate of the epidural catheter was reported to be 15%. The investigators will examine the effect of continuous peritoneal analgesic postoperative pain control in patients undergoing open PD to improve postoperative pain management and to create an our own ERAS program. To this end, The investigators will test non-inferiority between epidural analgesia and peritoneal analgesia.

Interventions

The device is connected to the epidural catheter prior to surgery and drug administration is started during surgery. The continuous infusion rate is 4 ml / hr. When the button is pressed, 2 ml is additionally administered and the lock time is 20 minutes.

DEVICEPreperitoneal analgesia and IV-PCA

During surgery, the preperitoneal analgesia catheters are inserted into the preperitoneal space and these catheters are connected to the pump with ropivacaine.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years and older * Disease of periampullary lesions * Elective open pancreaticoduodenectomy (PD): PD or pylorus preserving pancreaticoduodenectomy (PPPD) * Midline incision * Written informed consent : ability to understand and the willingness to sign a written informed consent * Performance status (ECOG scale): 0-1 at the time of enrollment * Physical status (ASA) : 1-2 grade

Exclusion criteria

* History of any abdominal surgery (except laparoscopic appendectomy, laparoscopic/robotic cholecystectomy, laparoscopic/robotic obstetrics and gynecology surgeries,Cesarean section, laparoscopic/robotic prostate surgery) * Emergency operation * History of chronic pain * Chronic use of opioid, analgesics, anti-depressant, anti-epileptics (\>1year) * Alcoholics * Impossible to control PCA d/t delirium, cognitive impairment * Contraindication for epidural analgesia * Patients with coagulopathy (INR\>1.5, Prothrombin time\>1.5, platelets \<80x10\^9perL) or anti-coagulants * Hypersensitive to fentanyl and ropivacaine * Need other organ resection (ex. Liver, colon) * Intubation

Design outcomes

Primary

MeasureTime frameDescription
Mean numerical rating score for pain after operation1-3 days after operationThe scale of the numerical rating score for pain is 0\ 10 and higher score is worse outcome. Mean NRS pain scores are compared between two groups.

Secondary

MeasureTime frameDescription
QoR-15 Surveypostoperative day 1,2,and 3QoR-15 survey on postoperative day 1,2,and 3.
Recovery related factorsWithin 1 week after operationTime to first eat meal, time to first move, time to first gas out
Postoperative complication factorsWithin 1 week after operationClavien-Dindo classification, postoperative pancreatic fistula
Pain related factorspostoperative day 1,2,and 3The scale of the numerical rating score for pain is 0\ 10 and higher score is worse outcome. Numerical rating score for pain on postoperative day 1, 2 and 3 at 4pm
Opioid related factorspostoperative day 1,2,and 3nausea, hypotension, respiratory depression
Hospital stayat dischargepostoperative hospital stay day
analgesic related factorspostoperative day 1,2,and 3rescue analgesics amounts, opioid amounts

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026